For Libraries For Publication Open Access Downloads About Us Contact Us
Paper Titles
Influence of Impeller Design on Hemolysis of an Axial Blood Pump
p.162
Investigations of the Effects of Epigallocatechin-3-Gallate and Co2+ on Cal-27 Cells In Vitro
p.167
Modelling and Simulation Radial and Tangential Dipoles of Human Head Local Field Potentials
p.172
MRI and MRA Diagnosis of Intracranial Aneurysms
p.178
Nalidixic Acid Resistance and Clonal Expansion of Salmonella enterica Serotype Paratyphi a Isolates in Yuxi City, China
p.183
Neural Respiratory Drive during CO2 Rebreathing Assessed by a Combined Esophageal Electrode Catheter
p.191
Numerical Simulations of the Non-Newtonian Blood Blow in Human Abdominal Artery Based on Reverse Engineering
p.195
Preparation and Evaluation of Daidzein Loaded Self-Microemulsifying Drug Delivery System
p.200
Radiological Abnormalities and Clinical Characteristics for Children with Kashin-Beck Disease in Tibet
p.206

Nalidixic Acid Resistance and Clonal Expansion of Salmonella enterica Serotype Paratyphi a Isolates in Yuxi City, China

Article Preview

Abstract:

The aim of our study was to understand the nalidixic acid resistance and clonal expansion of Salmonella enterica serotype Paratyphi A (SPA) recovered from patients with paratyphoid fever A in Yuxi City from 1999 to 2008. A typing method is needed to determine the epidemic clones of the isolates. Antimicrobial susceptibility testing was performed with 4 060 SPA isolates. 186 isolates were typed by pulsed-field gel electrophoresis (PFGE) with SpeI, and the MICs for nalidixic acid, ciprofloxacin, levofloxacin, ofloxacin, norfloxacin, and gatifloxacin were determined. The incidence of resistance to nalidixic acid of the isolates increased from 12.5% in 1999, 82.2% in 2000, 93.0% in 2001, to100% in 2008. Nalidixic acid-susceptible (NAS) isolates predominated in 1999 but was replaced by nalidixic acid-resistant (NAR) isolates after 2000. The frequencies of intermediary and susceptibility (Kirby-Bauer disc diffusion technique) to ciprofloxacin were 17.0% and 83.0% before 2005, 65.3% and 34.7% in 2008, respectively. A group of 166 NAR and 20 NAS isolates of SPA were randomly selected. SpeI digestion of 186 isolates gave nine different PFGE patterns with predominance of the SpeI01 and SpeI02 epidemic patterns. All NAR isolates studied had a reduced susceptibility to fluoroquinolone, the MICs were higher than that for 20 NAS isolates.We validate the use of the nalidixic acid screening test in the detection of decreased fluoroquinolone susceptibility in SPA. PFGE patterns SpeI01 and SpeI02, the main clones of the epidemics, are highly prevalent and NAR isolates in Yuxi. Recommendation for the emergency treatments of outbreaks and epidemics caused by a fully fluoroquinolone-resistant strain can be made. PFGE with SpeI is a useful technique to differentiate SPA.

You might also be interested in these eBooks
Medical Materials and Engineering View Preview

Info:

Periodical:

Applied Mechanics and Materials (Volume 140)

Pages:

183-190

DOI:

https://doi.org/10.4028/www.scientific.net/AMM.140.183

Citation:

Cite this paper

Online since:

November 2011

Authors:

Ying Bo Yao, Shu Kun Wang, Cong Jia Chu, Biao Kan

Keywords:

Antimicrobial Susceptibility, Clonal Expansion, Paratyphoid Fever, PFGE, Salmonella enterica Serotype Paratyphi

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

© 2012 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

References

[1] M.K. Bhan, B. Rajiv, B. Shinjini, Typhoid and paratyphoid fever, Lancet. 366(2005)749-762.

DOI: 10.1016/s0140-6736(05)67181-4

Google Scholar

[2] K. Molbak, Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens, Clin. Infect. Dis. 41(2005)1613-1620.

DOI: 10.1086/497599

Google Scholar

[3] T.A.H Le, L. Fabre, P. Roumagnac,Clonal expansion and microevolution of quinolone-resistant Salmonella enterica serotype typhi in Vietnam from 1996 to 2004. J. Clin. Microbiol. 45(2007) 3485-3492.

DOI: 10.1128/jcm.00948-07

Google Scholar

[4] T. Kadhiravan, N. Wig, N, Kapil, Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect. Dis. 5(2005)37.

DOI: 10.1186/1471-2334-5-37

Google Scholar

[5] J.A. Crup, K. Kretsinger, K. Gay, Clinical response and outcome of infection with Salmonella enterica serotype typhi with decreased susceptibility to fluoroquinolones: a United States FoodNet multicenter retrospective cohort study. Antimicrob.Agents.Chemother. 52(2008)1278-1284.

DOI: 10.1128/aac.01509-07

Google Scholar

[6] T. Dimitrov, E.E. Udo, O. Albaksami, Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin. J. Med. Microbiol. 56(2007)277-279.

DOI: 10.1099/jmm.0.46773-0

Google Scholar

[7] D.S. Chandel, R.Chaudhry, B. Dhawan, Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg. Infect. Dis. 6(2000)420-421.

DOI: 10.3201/eid0604.000420

Google Scholar

[8] S. Hume, T. Schulz, P. Vinton, Increasing rates and clinical consequences of nalidixic acid-resistant isolates causing enteric fever in returned travelers: 18-year experience. Eur J Clin Microbiol Infect Dis 2009, published online: 09 April 2009

DOI: 10.1007/S10096-009-0732-6

Google Scholar

[9] Shukun Wang, Chujia Chu, Peishi Sun: Study on blood cultures and bacteria counts in blood of paratyphoid fever A patients. Eur. J. Clin. Microbiol. Infect. Dis. 2009, published online:14 June 2009

DOI: 10.1007/S10096-009-0766-9

Google Scholar

[10] K. Fanlin, C. Congjia, G, Xinlong, Drug-resistant change of Salmonella enterica serotype Paratyphi A in Yuxi territory of Yunnan province. Chinese Journal of Clinical Pharmacy. 14(2005)182-184.

Google Scholar

[11] W. Shukun, Y. Yunbo, C. Congjia, Clonal expansion and genetic diversity of nalidixic acid-resistant Salmonella enterica serotype Paratyphi A in Yuxi city, China. Chinese Journal of Microbiology and Immunology. 28(2008)1109-1115.

DOI: 10.5897/ajmr-11-1260

Google Scholar

[12] Z.Hongqian, W. Shukun, W. Yanfan: Epidemic analysis of typhoid and paratyphoid fever A from 1998 through 2004 in Hongta area of Yuxi city. Chinese Journal of Natural Medicine. 10(2008)401-405.

Google Scholar

[13] R.S. Hendriksen. A global Salmonella surveillance and laboratory support project of the World Health Organization: Laboratory Protocols Level 1 Training Course Identification of Salmonella 4th Ed. April 2003.

Google Scholar

[14] Clinical and Laboratory Standards Institute, (2009) Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. CLSI document no. M100-S19, Vol.29. No.3.

Google Scholar

[15] A.J. Hakanen, M. Lindgren, P. Huovinen, New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility. J. Clin. Microbiol. 43(2005)5775-5778.

DOI: 10.1128/jcm.43.11.5775-5778.2005

Google Scholar

[16] S.B. Gaul, Wedel S, Erdman MM: Use of pulsed-field gel electrophoresis of conserved XbaI fragments for identification of swine Salmonella serotypes. J. Clin. Microbiol. 45(2007) 472-476.

DOI: 10.1128/jcm.00962-06

Google Scholar

[17] C.H. Sandt, D.A. Krouse, C.R. Cook, The key role of pulsed-field gel electrophoresis in investigation of a large multiserotype and multistate food-borne outbreak of Salmonella infections centered in Pennsylvania. J. Clin. Microbiol. 44 (2006)3208-3212.

DOI: 10.1128/jcm.01404-06

Google Scholar

[18] K.L. Hopkins, R.H. Davies, E.J. Threlfall, Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Agents. 25(2005)358-373.

DOI: 10.1016/j.ijantimicag.2005.02.006

Google Scholar

[19] B. Swaminathan, T.J. Barrett, S.B. Hunter, The molecular subtyping network for foodborne bacterial disease surveillance, United State. Emerging Infectious Diseases, 7(2001)382-389.

DOI: 10.3201/eid0703.017303

Google Scholar

[20] E.J. Threlfall, M. Day, E. de Pinna, Drug-resistant enteric fever in the UK. Lancet, 367(2006) 1576.

DOI: 10.1016/s0140-6736(06)68691-1

Google Scholar

[21] H. Solnik-Isaac, M. Weinberger, M.Tabak, Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansion. J. Clin. Microbiol. 45(2007)2575-2579.

DOI: 10.1128/jcm.00062-07

Google Scholar

[22] E. Giraud, S. Baucheron, A .Cloeckaert, Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microbes. Infect. 8(2006)1937-1944.

DOI: 10.1016/j.micinf.2005.12.025

Google Scholar

[23] S. Bertrand, F.X. Weill, A.Cloeckaert, Clonal emergence of extended-spectrum beta-lactamase (CTX-M-2)-producing Salmonella server Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J.Clin Microbiol. 44(2006)2897-2903.

DOI: 10.1128/jcm.02549-05

Google Scholar

[24] D. Kilmartin, D. Morris, C.G. O,Hare, Clonal expansion may account for high levels of quinolone resistance in Salmonella enterica severovar Enteritidis. Appl. Environ. Microbiol. 71(2005)2587-2591.

DOI: 10.1128/aem.71.5.2587-2591.2005

Google Scholar

[25] I.Stock, B. Wiedemann, Natural antibiotic susceptibility of Salmonella enterica strains. Int. J. Antimicrob. Agents. 16(2000)211-217.

DOI: 10.1016/s0924-8579(00)00204-1

Google Scholar

© 2025 Trans Tech Publications Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For open access content, terms of the Creative Commons licensing CC-BY are applied.
Scientific.Net is a registered trademark of Trans Tech Publications Ltd.